The present application provides compounds that are PAPD5 inhibitors and are useful in treating a variety of conditions such as cancer, telomere diseases, and aging-related and other degenerative disorders.
-
Page/Page column 161-162
(2020/11/03)
More Articles about upstream products of 5623-11-0